Enanta Pharmaceuticals (ENTA) Profit After Tax (QoQ) (2012 - 2026)
Enanta Pharmaceuticals (ENTA) Profit After Tax (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Enanta Pharmaceuticals | 369.97 Mn | 206.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.66% |
| Dec 31, 2025 | 36.16% |
| Sep 30, 2025 | -2.44% |
| Jun 30, 2025 | 19.38% |
| Mar 31, 2025 | -1.59% |
| Dec 31, 2024 | 22.67% |
| Sep 30, 2024 | -27.21% |
| Jun 30, 2024 | 27.28% |
| Mar 31, 2024 | 6.74% |
| Dec 31, 2023 | -18.86% |
| Sep 30, 2023 | 28.05% |
| Jun 30, 2023 | -3.74% |
| Mar 31, 2023 | -29.92% |
| Dec 31, 2022 | -10.01% |
| Sep 30, 2022 | 16.88% |
| Jun 30, 2022 | 5.63% |
| Mar 31, 2022 | -11.55% |
| Dec 31, 2021 | -22.42% |
| Sep 30, 2021 | -2.39% |
| Jun 30, 2021 | -8.98% |